Immunotherapy and Emerging Targeted Therapies

Explore how immunotherapies and novel targeted treatments are reshaping breast cancer care. This session will cover immune checkpoint inhibitors, cancer vaccines, and CAR-T cell therapies in clinical trials. Discussions will also address PARP inhibitors, CDK4/6 inhibitors, and antibody-drug conjugates. Attendees will gain insights into the latest research, real-world case studies, and the promise of combining immunotherapy with traditional modalities for better clinical outcomes

    Related Conference of Immunotherapy and Emerging Targeted Therapies

    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    August 10-11, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    September 07-08, 2026

    26th World Congress on Cancer and Diagnostics

    Paris, France
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France

    Immunotherapy and Emerging Targeted Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in